e-learning
resources
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Conditional expanding post-exposure prophylaxis: a potential new tool for tuberculosis control
Henan Xin, Qi Jin, Lei Gao
Source:
ERJ Open Res, 7 (1) 00723-2020; 10.1183/23120541.00723-2020
Journal Issue:
January
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Henan Xin, Qi Jin, Lei Gao. Conditional expanding post-exposure prophylaxis: a potential new tool for tuberculosis control. ERJ Open Res, 7 (1) 00723-2020; 10.1183/23120541.00723-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Cost-effectiveness of two latent tuberculosis infection screening strategies
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018
New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Evolution of the strategies for control and elimination of tuberculosis
Source: Eur Respir Monogr 2018; 82: 36-61
Year: 2018
Evolution of TB control and elimination strategies
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources
Source: Eur Respir J 2006; 28: Suppl. 50, 28s
Year: 2006
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Source: Eur Respir J 2012; 39: 626-634
Year: 2012
Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
Source: Eur Respir J 2013; 42: 1449-1453
Year: 2013
The case for assessing the full value of new tuberculosis vaccines
Source: Eur Respir J, 55 (3) 1902414; 10.1183/13993003.02414-2019
Year: 2020
From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections
Source: International Congress 2017 – Scientific year in review
Year: 2017
The WHO-recommended strategy of tuberculosis control: the new vision of DOTS
Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?
Year: 2007
Latent tuberculosis infection: a new paradigm
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019
What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Source: Eur Respir Monogr 2018; 82: 414-429
Year: 2018
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
Source: Eur Respir J 2015; 45: 569-571
Year: 2015
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
Source: Eur Respir J 2015; 45: 571-574
Year: 2015
Framework for the evaluation of new tests for tuberculosis infection
Source: Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020
Year: 2021
Effects of DOTS strategy on new confirmed tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 588s
Year: 2006
Mobilising community networks for early identification of tuberculosis and treatment initiation in Cambodia: an evaluation of a seed-and-recruit model
Source: ERJ Open Res, 6 (2) 00368-2019; 10.1183/23120541.00368-2019
Year: 2020
Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept